Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...

Face east around 9-9:30 p.m. in mid-April and you can't miss shimmering orange Arcturus, the brightest star in the constellation Bootes the Bear Guardian. Two fists to the lower left of Arcturus, look ...

The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...

A new subvariant of COVID-19 is proliferating in the US and is now responsible for nearly 10% of all new cases, according to alerts from the Centers for Disease Control and Prevention and the World ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. In a brief ...

Earnings Call Insights: Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic ...

Los Angeles County Department of Public Health confirmed three cases of the Arcturus strain with "observational data" suggesting that those infected may be likely to experience pink eye Alexis Jones ...

Los Angeles County has identified its first cases of an emerging Omicron coronavirus subvariant dubbed Arcturus, a strain global health authorities are watching closely as it has been linked to an ...

Arcturus' mRNA vaccine will be trying to break into a crowded market if it gets approved. Moderna was in the right place at the right time, and Arcturus isn't. Yet, Arcturus doesn't need to sell many ...